Related Experiment Video
Updated: May 2, 2026

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
Elucidating thoracic aortic dissection pathogenesis: The interplay of m1A-related gene expressions and
Kun Liu1, Yuemeng Li2, Fanxing Yin3
1Department of Cardiac Surgery, Affiliated Hospital, Guizhou Medical University, Guiyang, China.
Abstract:
The underlying molecular mechanisms of thoracic aortic dissection (TAD) remain incompletely understood. Recent insights into RNA methylation and microRNA-mediated gene regulation offer new avenues for exploring how these processes contribute to the pathophysiology of TAD, particularly through the modulation of pyroptosis and smooth muscle cell viability. This research aimed to elucidate the interplay of m1A-related gene expressions and miR-16-5p/YTHDC1 Axis in NLRP3-dependent pyroptosis, a mechanism implicated in the pathogenesis of TAD. We collected tissue samples from 28 human TAD patients and 8 healthy aortic group, as well as utilized a mouse model to replicate the disease. A combination of computational, in vitro, and in vivo methods was applied, including CIBERSORTx analysis, Pearson correlation, gene transfection using antagomiR-16-5p, siRNA, and several staining as well as cell culture techniques. Our analysis indicated two differentially expressed genes, ALKBH2 and YTHDC1. We found significant upregulation of has-miR-16-5p and downregulation of YTHDC1 at mRNA level in AD samples. Immune cell infiltration in TAD samples was examined using the CIBERSORTx database. We confirmed that YTHDC1 was a target of miR-16-5p, as evidenced by an inhibitory effect on luciferase activity. Inhibition of miR-16-5p enhanced SMC proliferation and promoted cell viability whilst downregulating NLRP3-pyroptosis. YTHDC1 expression was increased, and NLRP3-pyroptosis expressions were inhibited, suggesting miR-16-5p/YTHDC1 axis may involve the NLRP3-pyroptosis of the SMC. In vivo analyses confirmed the prevention of NLRP3-pyroptosis in middle layer of the thoracic aorta, implying that the miR-16-5p/YTHDC1 axis regulated SMC proliferation via NLRP3-pyroptosis signaling. Our findings underscored the anti-pyroptotic role of miR-16-5p/YTHDC1 axis in the pathogenesis of TAD, suggesting a potential therapeutic strategy via targeting YTHDC1 and suppressing miR-16-5p to inhibit NLRP3-dependent pyroptosis. Although further investigation is needed, these results relating to SMC proliferation are a significant step forward in understanding TAD.
Insights
This study reveals the miR-16-5p/YTHDC1 axis plays an anti-pyroptotic role in thoracic aortic dissection (TAD). Targeting YTHDC1 and suppressing miR-16-5p may offer new therapeutic strategies for TAD.
Area of Science:
- Cardiovascular Biology
- Molecular Mechanisms of Disease
- RNA Biology
Background:
- Thoracic aortic dissection (TAD) mechanisms are not fully understood.
- RNA methylation and microRNA regulation are emerging factors in TAD.
- Pyroptosis and smooth muscle cell (SMC) viability are key in TAD pathogenesis.
Purpose of the Study:
- To investigate the role of m1A-related gene expression and the miR-16-5p/YTHDC1 axis in NLRP3-dependent pyroptosis in TAD.
- To elucidate the interplay between these factors and their impact on SMC viability and proliferation.
Main Methods:
- Analysis of human TAD and healthy aortic tissue samples (n=28 vs 8) and a mouse model.
- Utilized CIBERSORTx, Pearson correlation, gene transfection (antagomiR-16-5p, siRNA), luciferase assays, and cell staining.
- Employed computational, in vitro, and in vivo approaches.
Main Results:
- Identified ALKBH2 and YTHDC1 as differentially expressed genes in TAD.
- Found miR-16-5p upregulated and YTHDC1 downregulated in TAD samples.
- Demonstrated that miR-16-5p targets YTHDC1, inhibiting NLRP3-pyroptosis and promoting SMC proliferation.
Conclusions:
- The miR-16-5p/YTHDC1 axis exhibits an anti-pyroptotic function in TAD pathogenesis.
- This axis regulates SMC proliferation through NLRP3-pyroptosis signaling.
- Targeting YTHDC1 and miR-16-5p presents a potential therapeutic avenue for TAD.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Pneumothorax II: Pathophysiology
Inflammatory Bowel Disease III: Crohn's Disease

